GCN5 inhibits XBP-1S-mediated transcription by antagonizing PCAF action

Oncotarget

Volumn 6, Issue 1, 2015, Pages 271-287

  Lew, Qiao Jing ^a   Chu, Kai Ling ^a   Chia, Yi Ling ^a   Soo, Benjamin ^a   Ho, Jia Pei ^a   Ng, Chew Har ^a   Kwok, Hui Si ^a   Chiang, Cheng Ming ^b   Chang, Yao ^c   Chao, Sheng Hao ^a,d  

^a AGENCY FOR SCIENCE   (Singapore)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

EBV LMP1; GCN5; PCAF; UPR; XBP 1S

Indexed keywords

HISTONE ACETYLTRANSFERASE GCN5; HISTONE ACETYLTRANSFERASE PCAF; UNCLASSIFIED DRUG; X BOX BINDING PROTEIN 1; X BOX BINDING PROTEIN 1S; DNA BINDING PROTEIN; P300-CBP-ASSOCIATED FACTOR; REGULATORY FACTOR X TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR; XBP1 PROTEIN, HUMAN;

ACETYLATION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; GENE DISRUPTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION REGULATION; UBIQUITINATION; UNFOLDED PROTEIN RESPONSE; UPR GENE; BIOSYNTHESIS; CHROMATIN IMMUNOPRECIPITATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; METABOLISM; PHYSIOLOGY; POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION; TUMOR CELL LINE; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; DNA-BINDING PROTEINS; HUMANS; IMMUNOPRECIPITATION; P300-CBP TRANSCRIPTION FACTORS; POLYMERASE CHAIN REACTION; REGULATORY FACTOR X TRANSCRIPTION FACTORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION; TRANSFECTION; X-BOX BINDING PROTEIN 1;

EID: 84921405901     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.2773     Document Type: Article

References (72)

1. Iwakoshi NN, Lee AH, Vallabhajosyula P, Otipoby KL, Rajewsky K and Glimcher LH. Plasma cell differentiation and the unfolded protein response intersect at the transcription factor XBP-1. Nat Immunol. 2003; 4(4):321-329.
2. Reimold AM, Iwakoshi NN, Manis J, Vallabhajosyula P, Szomolanyi-Tsuda E, Gravallese EM, Friend D, Grusby MJ, Alt F and Glimcher LH. Plasma cell differentiation requires the transcription factor XBP-1. Nature. 2001; 412(6844):300-307.
3. Brewer JW and Hendershot LM. Building an antibody factory: a job for the unfolded protein response. Nat Immunol. 2005; 6(1):23-29.
4. Yoshida H, Matsui T, Yamamoto A, Okada T and Mori K. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell. 2001; 107(7):881-891.
5. Uemura A, Oku M, Mori K and Yoshida H. Unconventional splicing of XBP1 mRNA occurs in the cytoplasm during the mammalian unfolded protein response. J Cell Sci. 2009; 122(Pt 16):2877-2886.
6. Yoshida H, Oku M, Suzuki M and Mori K. pXBP1(U) encoded in XBP1 pre-mRNA negatively regulates unfolded protein response activator pXBP1(S) in mammalian ER stress response. J Cell Biol. 2006; 172(4):565-575.
7. Lee AH, Iwakoshi NN and Glimcher LH. XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response. Mol Cell Biol. 2003; 23(21):7448-7459.
8. Sriburi R, Jackowski S, Mori K and Brewer JW. XBP1: a link between the unfolded protein response, lipid biosynthesis, and biogenesis of the endoplasmic reticulum. J Cell Biol. 2004; 167(1):35-41.
9. Ku SC, Ng DT, Yap MG and Chao SH. Effects of overexpression of X-box binding protein 1 on recombinant protein production in Chinese hamster ovary and NS0 myeloma cells. Biotechnol Bioeng. 2008; 99(1):155-164.
10. Ku SC, Toh PC, Lee YY, Chusainow J, Yap MG and Chao SH. Regulation of XBP-1 signaling during transient and stable recombinant protein production in CHO cells. Biotechnol Prog. 2010; 26(2):517-526.
11. Saito S, Furuno A, Sakurai J, Sakamoto A, Park HR, Shin-Ya K, Tsuruo T and Tomida A. Chemical genomics identifies the unfolded protein response as a target for selective cancer cell killing during glucose deprivation. Cancer Res. 2009; 69(10):4225-4234.
12. Romero-Ramirez L, Cao H, Nelson D, Hammond E, Lee AH, Yoshida H, Mori K, Glimcher LH, Denko NC, Giaccia AJ, Le QT and Koong AC. XBP1 is essential for survival under hypoxic conditions and is required for tumor growth. Cancer Res. 2004; 64(17):5943-5947.
13. Papandreou I, Denko NC, Olson M, Van Melckebeke H, Lust S, Tam A, Solow-Cordero DE, Bouley DM, Offner F, Niwa M and Koong, AC. Identification of an Ire1alpha endonuclease specific inhibitor with cytotoxic activity against human multiple myeloma. Blood. 2011; 117(4):1311-1314.
14. Mimura N, Fulciniti M, Gorgun G, Tai YT, Cirstea D, Santo L, Hu Y, Fabre C, Minami J, Ohguchi H, Kiziltepe T, Ikeda H, Kawano Y, French M, Blumenthal M, Tam V, et al. Blockade of XBP1 splicing by inhibition of IRE1alpha is a promising therapeutic option in multiple myeloma. Blood. 2012; 119(24):5772-5781.
15. Ri M, Tashiro E, Oikawa D, Shinjo S, Tokuda M, Yokouchi Y, Narita T, Masaki A, Ito A, Ding J, Kusumoto S, Ishida T, Komatsu H, Shiotsu Y, Ueda R, Iwawaki T, et al. Identification of Toyocamycin, an agent cytotoxic for multiple myeloma cells, as a potent inhibitor of ER stressinduced XBP1 mRNA splicing. Blood Cancer J. 2012; 2(7):e79.
16. Jenner RG, Maillard K, Cattini N, Weiss RA, Boshoff C, Wooster R and Kellam P. Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma has a plasma cell gene expression profile. Proc Natl Acad Sci U S A. 2003; 100(18):10399-10404.
17. Medigeshi GR, Lancaster AM, Hirsch AJ, Briese T, Lipkin WI, Defilippis V, Fruh K, Mason PW, Nikolich-Zugich J and Nelson JA. West Nile virus infection activates the unfolded protein response, leading to CHOP induction and apoptosis. J Virol. 2007; 81(20):10849-10860.
18. Su HL, Liao CL and Lin YL. Japanese encephalitis virus infection initiates endoplasmic reticulum stress and an unfolded protein response. J Virol. 2002; 76(9):4162-4171.
19. Tardif KD, Mori K, Kaufman RJ and Siddiqui A. Hepatitis C virus suppresses the IRE1-XBP1 pathway of the unfolded protein response. J Biol Chem. 2004; 279(17):17158-17164.
20. Tardif KD, Mori K and Siddiqui A. Hepatitis C virus subgenomic replicons induce endoplasmic reticulum stress activating an intracellular signaling pathway. J Virol. 2002; 76(15):7453-7459.
21. Li B, Gao B, Ye L, Han X, Wang W, Kong L, Fang X, Zeng Y, Zheng H, Li S and Wu Z. Hepatitis B virus X protein (HBx) activates ATF6 and IRE1-XBP1 pathways of unfolded protein response. Virus Res. 2007; 124(1-2):44-49.
22. Tirosh B, Iwakoshi NN, Lilley BN, Lee AH, Glimcher LH and Ploegh HL. Human cytomegalovirus protein US11 provokes an unfolded protein response that may facilitate the degradation of class I major histocompatibility complex products. J Virol. 2005; 79(5):2768-2779.
23. Isler JA, Skalet AH and Alwine JC. Human cytomegalovirus infection activates and regulates the unfolded protein response. J Virol. 2005; 79(11):6890-6899.
24. Yu CY, Hsu YW, Liao CL and Lin YL. Flavivirus infection activates the XBP1 pathway of the unfolded protein response to cope with endoplasmic reticulum stress. J Virol. 2006; 80(23):11868-11880.
25. Chan CP, Siu KL, Chin KT, Yuen KY, Zheng B and Jin DY. Modulation of the unfolded protein response by the severe acute respiratory syndrome coronavirus spike protein. J Virol. 2006; 80(18):9279-9287.
26. Bechill J, Chen Z, Brewer JW and Baker SC. Coronavirus infection modulates the unfolded protein response and mediates sustained translational repression. J Virol. 2008; 82(9):4492-4501.
27. Barry G, Fragkoudis R, Ferguson MC, Lulla A, Merits A, Kohl A and Fazakerley JK. Semliki forest virus-induced endoplasmic reticulum stress accelerates apoptotic death of mammalian cells. J Virol. 2010; 84(14):7369-7377.
28. Yu C, Achazi K and Niedrig M. Tick-borne encephalitis virus triggers inositol-requiring enzyme 1 (IRE1) and transcription factor 6 (ATF6) pathways of unfolded protein response. Virus Res. 2013; 178(2):471-477.
29. Jheng JR, Lin CY, Horng JT and Lau KS. Inhibition of enterovirus 71 entry by transcription factor XBP1. Biochem Biophys Res Commun. 2012; 420(4):882-887.
30. Abraham R, Mudaliar P, Padmanabhan A and Sreekumar E. Induction of cytopathogenicity in human glioblastoma cells by chikungunya virus. PLoS One. 2013; 8(9):e75854.
31. Carpenter JE, Jackson W, Benetti L and Grose C. Autophagosome formation during varicella-zoster virus infection following endoplasmic reticulum stress and the unfolded protein response. J Virol. 2011; 85(18):9414-9424.
32. Zhang HM, Ye X, Su Y, Yuan J, Liu Z, Stein DA and Yang D. Coxsackievirus B3 infection activates the unfolded protein response and induces apoptosis through downregulation of p58IPK and activation of CHOP and SREBP1. J Virol. 2010; 84(17):8446-8459.
33. Hassan IH, Zhang MS, Powers LS, Shao JQ, Baltrusaitis J, Rutkowski DT, Legge K and Monick MM. Influenza A viral replication is blocked by inhibition of the inositolrequiring enzyme 1 (IRE1) stress pathway. J Biol Chem. 2012; 287(7):4679-4689.
34. Ku SC, Lee J, Lau J, Gurumurthy M, Ng R, Lwa SH, Klase Z, Kashanchi F and Chao SH. XBP-1, a novel human T-lymphotropic virus type 1 (HTLV-1) tax binding protein, activates HTLV-1 basal and tax-activated transcription. J Virol. 2008; 82(9):4343-4353.
35. Hsiao JR, Chang KC, Chen CW, Wu SY, Su IJ, Hsu MC, Jin YT, Tsai ST, Takada K and Chang Y. Endoplasmic reticulum stress triggers XBP-1-mediated up-regulation of an EBV oncoprotein in nasopharyngeal carcinoma. Cancer Res. 2009; 69(10):4461-4467.
36. Yoshida M, Miyoshi I and Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci U S A. 1982; 79(6):2031-2035.
37. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD and Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980; 77(12):7415-7419.
38. Alefantis T, Mostoller K, Jain P, Harhaj E, Grant C and Wigdahl B. Secretion of the human T cell leukemia virus type I transactivator protein tax. J Biol Chem. 2005; 280(17):17353-17362.
39. Young LS and Rickinson AB. Epstein-Barr virus: 40 years on. Nat Rev Cancer. 2004; 4(10):757-768.
40. Miller WE, Earp HS and Raab-Traub N. The Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor. J Virol. 1995; 69(7):4390-4398.
41. Murono S, Inoue H, Tanabe T, Joab I, Yoshizaki T, Furukawa M and Pagano JS. Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells. Proc Natl Acad Sci U S A. 2001; 98(12):6905-6910.
42. Lew QJ, Chu KL, Lee J, Koh PL, Rajasegaran V, Teo JY and Chao SH. PCAF interacts with XBP-1S and mediates XBP-1S-dependent transcription. Nucleic Acids Res. 2011; 39(2):429-439.
43. Nagy Z and Tora L. Distinct GCN5/PCAF-containing complexes function as co-activators and are involved in transcription factor and global histone acetylation. Oncogene. 2007; 26(37):5341-5357.
44. Yamamoto K, Yoshida H, Kokame K, Kaufman RJ and Mori K. Differential contributions of ATF6 and XBP1 to the activation of endoplasmic reticulum stress-responsive cis-acting elements ERSE, UPRE and ERSE-II. J Biochem. 2004; 136(3):343-350.
45. Yamamoto K, Suzuki N, Wada T, Okada T, Yoshida H, Kaufman RJ and Mori K. Human HRD1 promoter carries a functional unfolded protein response element to which XBP1 but not ATF6 directly binds. J Biochem. 2008; 144(4):477-486.
46. Soutoglou E, Katrakili N and Talianidis I. Acetylation regulates transcription factor activity at multiple levels. Mol Cell. 2000; 5(4):745-751.
47. Kawai Y, Garduno L, Theodore M, Yang J and Arinze IJ. Acetylation-deacetylation of the transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2) regulates its transcriptional activity and nucleocytoplasmic localization. J Biol Chem. 2011; 286(9):7629-7640.
48. Thomas MC and Chiang CM. E6 oncoprotein represses p53-dependent gene activation via inhibition of protein acetylation independently of inducing p53 degradation. Mol Cell. 2005; 17(2):251-264.
49. Calfon M, Zeng H, Urano F, Till JH, Hubbard SR, Harding HP, Clark SG and Ron D. IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA. Nature. 2002; 415(6867):92-96.
50. Ciechanover A. Proteolysis: from the lysosome to ubiquitin and the proteasome. Nat Rev Mol Cell Biol. 2005; 6(1):79-87.
51. Paulson M, Press C, Smith E, Tanese N and Levy DE. IFN-Stimulated transcription through a TBP-free acetyltransferase complex escapes viral shutoff. Nat Cell Biol. 2002; 4(2):140-147.
52. Laptenko O and Prives C. The p53-HAT connection: PCAF rules? Cell Cycle. 2012; 11(16):2975-2976.
53. Eckner R. p53-dependent growth arrest and induction of p21: a critical role for PCAF-mediated histone acetylation. Cell Cycle. 2012; 11(14):2591-2592.
54. Love IM, Sekaric P, Shi D, Grossman SR and Androphy EJ. The histone acetyltransferase PCAF regulates p21 transcription through stress-induced acetylation of histone H3. Cell Cycle. 2012; 11(13):2458-2466.
55. Welihinda AA, Tirasophon W, Green SR and Kaufman RJ. Gene induction in response to unfolded protein in the endoplasmic reticulum is mediated through Ire1p kinase interaction with a transcriptional coactivator complex containing Ada5p. Proc Natl Acad Sci U S A. 1997; 94(9):4289-4294.
56. Sela D, Chen L, Martin-Brown S, Washburn MP, Florens L, Conaway JW and Conaway RC. Endoplasmic reticulum stress-responsive transcription factor ATF6alpha directs recruitment of the Mediator of RNA polymerase II transcription and multiple histone acetyltransferase complexes. J Biol Chem. 2012; 287(27):23035-23045.
57. Nagy Z, Riss A, Romier C, le Guezennec X, Dongre AR, Orpinell M, Han J, Stunnenberg H, Tora L: The human SPT20-containing SAGA complex plays a direct role in the regulation of endoplasmic reticulum stress-induced genes. Mol Cell Biol 2009, 29(6):1649-1660.
58. Schram AW, Baas R, Jansen PW, Riss A, Tora L, Vermeulen M and Timmers HT. A dual role for SAGAassociated factor 29 (SGF29) in ER stress survival by coordination of both histone H3 acetylation and histone H3 lysine-4 trimethylation. PLoS One. 2013; 8(7):e70035.
59. Lane AA and Chabner BA. Histone deacetylase inhibitors in cancer therapy. J Clin Oncol. 2009; 27(32):5459-5468.
60. Gu W and Roeder RG. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell. 1997; 90(4):595-606.
61. Boyes J, Byfield P, Nakatani Y and Ogryzko V. Regulation of activity of the transcription factor GATA-1 by acetylation. Nature. 1998; 396(6711):594-598.
62. Daitoku H, Hatta M, Matsuzaki H, Aratani S, Ohshima T, Miyagishi M, Nakajima T and Fukamizu A. Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity. Proc Natl Acad Sci U S A. 2004; 101(27):10042-10047.
63. Downey M, Knight B, Vashisht AA, Seller CA, Wohlschlegel JA, Shore D and Toczyski DP. Gcn5 and sirtuins regulate acetylation of the ribosomal protein transcription factor Ifh1. Curr Biol. 2013; 23(17):1638-1648.
64. Kim JH, Saraf A, Florens L, Washburn M and Workman JL. Gcn5 regulates the dissociation of SWI/SNF from chromatin by acetylation of Swi2/Snf2. Genes Dev. 2010; 24(24):2766-2771.
65. Koong AC, Chauhan V and Romero-Ramirez L. Targeting XBP-1 as a novel anti-cancer strategy. Cancer Biol Ther. 2006; 5(7):756-759.
66. Chien W, Ding LW, Sun QY, Torres-Fernandez LA, Tan SZ, Xiao J, Lim SL, Garg M, Lee KL, Kitajima S, Takao S, Leong WZ, Sun H, Tokatly I, Poellinger L, Gery S, et al. Selective inhibition of unfolded protein response induces apoptosis in pancreatic cancer cells. Oncotarget. 2014; 5(13):4881-4894.
67. Rico-Bautista E, Zhu W, Kitada S, Ganapathy S, Lau E, Krajewski S, Ramirez J, Bush JA, Yuan Z and Wolf DA. Small molecule-induced mitochondrial disruption directs prostate cancer inhibition via UPR signaling. Oncotarget. 2013; 4(8):1212-1229.
68. Foulkes WD, Smith IE and Reis-Filho JS. Triple-negative breast cancer. N Engl J Med. 2010; 363(20):1938-1948.
69. Chen X, Iliopoulos D, Zhang Q, Tang Q, Greenblatt MB, Hatziapostolou M, Lim E, Tam WL, Ni M, Chen Y, Mai J, Shen H, Hu DZ, Adoro S, Hu B, Song M, et al. XBP1 promotes triple-negative breast cancer by controlling the HIF1alpha pathway. Nature. 2014; 508(7494):103-107.
70. Yu F, Feng J, Harada JN, Chanda SK, Kenney SC and Sun R. B cell terminal differentiation factor XBP-1 induces reactivation of Kaposi's sarcoma-associated herpesvirus. FEBS Lett. 2007; 581(18):3485-3488.
71. Yoshida H, Okada T, Haze K, Yanagi H, Yura T, Negishi M and Mori K. ATF6 activated by proteolysis binds in the presence of NF-Y (CBF) directly to the cis-acting element responsible for the mammalian unfolded protein response. Mol Cell Biol. 2000; 20(18):6755-6767.
72. Lin HC, Hickey M, Hsu L, Medina D and Rabson AB. Activation of human T cell leukemia virus type 1 LTR promoter and cellular promoter elements by T cell receptor signaling and HTLV-1 Tax expression. Virology. 2005; 339(1):1-11.